Literature DB >> 32420292

Surgical reconstruction of primary genital lymphedema-long term therapeutic efficacy.

Ziyou Yu1, Lingling Sheng1, Weigang Cao1, Shengli Li1, Wei Lu1, Weiqing Gao2, Zhaohua Jiang1.   

Abstract

BACKGROUND: Primary genital lymphedema is caused by congenital lymphatic dysplasia, which is often accompanied by lymphedema of the lower extremities. A lack of effective diagnostics and treatments are available in clinical practice. The purpose of this study is to present the experience of surgical treatment of genital lymphedema and follow-up magnetic resonance lymphangiography (MRL) examinations.
METHODS: The clinical records of 40 patients diagnosed with primary genital lymphedema between 2010 and 2019 were retrospectively reviewed. The surgical management of all patients consisted of complete excision of the edematous subcutaneous tissue and plastic reconstruction of the penis or scrotum. This involved excision of the affected tissue while retaining the scrotal septum, preserving the subcutaneous lymphatic tissue flap, turnover of the perididymis, and primary closure. All patients were examined by MRL to assess the extent of lymphedema pre- and postoperatively. The cosmetic results, recovery of sexual function, patient satisfaction, and complications are discussed.
RESULTS: A total of 40 patients underwent surgical treatment. Scrotal hematoma (2.5%) and poor wound healing (5%) were encountered postoperatively. During follow-up period, no recurrence of edema occurred. The appearance of the scrotum and penis, as well as the sexual function was improved. MRL confirmed tissue edema and lymphatic malformation in the enlarged penis and scrotum preoperatively. In follow-up MRL, new formation or reopen of lymphatic drainage can be detect in 25 (62.5%) patients. All patients showed decreased area of dermal backflow.
CONCLUSIONS: Surgical treatment is necessary for genital lymphedema when swelling develops. The use of a retained scrotal septum and subcutaneous lymphatic tissue flaps can achieve improved morphology and function. MRL is a safe and accurate diagnostic imaging method for pre- and postoperative evaluation of lymphedema in patients undergoing lymphatic surgery. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Genital lymphedema; magnetic resonance lymphangiography (MRL); surgical reconstruction

Year:  2020        PMID: 32420292      PMCID: PMC7225496          DOI: 10.21037/gs.2020.03.19

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  7 in total

1.  High-resolution MR lymphangiography in patients with primary and secondary lymphedema.

Authors:  Christian Lohrmann; Etelka Foeldi; Oliver Speck; Mathias Langer
Journal:  AJR Am J Roentgenol       Date:  2006-08       Impact factor: 3.959

2.  Congenital lymphoedema of the genitalia.

Authors:  R J Bolt; W Peelen; P G Nikkels; T P de Jong
Journal:  Eur J Pediatr       Date:  1998-11       Impact factor: 3.183

3.  Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.

Authors:  Ning-Fei Liu; Qing Lu; Zhao-Hua Jiang; Chen-Guang Wang; Jian-Guo Zhou
Journal:  J Vasc Surg       Date:  2009-02-15       Impact factor: 4.268

4.  Penile lymphoedema: approach to investigation and management.

Authors:  T N Shim; P R Doiron; N Francis; S Minhas; A Muneer; D Hawkins; M Dinneen; C B Bunker
Journal:  Clin Exp Dermatol       Date:  2018-07-15       Impact factor: 3.470

5.  Primary lymphedema in children and adolescents: a follow-up study and review.

Authors:  D M Smeltzer; G B Stickler; A Schirger
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

6.  The management of genital lymphoedema.

Authors:  Giulio Garaffa; Nim Christopher; David J Ralph
Journal:  BJU Int       Date:  2008-03-05       Impact factor: 5.588

7.  Assessment of The Lymphatic System of the Genitalia Using Magnetic Resonance Lymphography Before and After Treatment of Male Genital Lymphedema.

Authors:  Qing Lu; Zhaohua Jiang; Zizhou Zhao; Lianming Wu; Guangyu Wu; Shiteng Suo; Jianrong Xu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.